With a robust scientific-stage pipeline, Agenus harnesses a combination of proprietary antibody platforms, including Retrocyte Display screen™ and SECANT®, and ground breaking cell therapy methods, positioning by itself to be a essential contributor within the biotechnology and immunotherapy arena.Preserving independence and editorial independen